OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
March 02, 2010
Brief pharmaceutical news items for March 2010.
Analysis of the opportunities and challenges in the biosimilars market.
From last-minute product inserts to putting out fires, close calls are a common occurrence.
It's time to maintain a thorough traceable excipient trail.
If both sides of the aisle don't agree on even mild healthcare reform soon, the bill could die out.
The vice-president addresses shifts in process and more.
Pharmaceutical companies and their suppliers share approaches in risk mitigation in sourcing and ways to optimize the outsourced relationship.
March 01, 2010
The second annual Pharmaceutical Technology Bioprocessing Survey offers a snapshot of the industry following 2009's megamergers.
The author examines the use and advantages of disposable technologies in the fill–finish of sterile pharmaceutical products and how these technologies can reduce costs and time in producing clinical-trial materials.
February 25, 2010
Merck To Eliminate 15,000 jobs; Tauzin Stepping Down At PhRMA; And More.